1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MAP2K1 CTRPv2 pan-cancer AAC -0.17 8e-07
mRNA RNASE6 CTRPv2 pan-cancer AAC 0.17 8e-07
mRNA MAST1 CTRPv2 pan-cancer AAC 0.19 9e-07
mRNA CDKN2C CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA RIMKLA CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA NPIPA1 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA FBXO25 CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA RNF138 CTRPv2 pan-cancer AAC 0.19 1e-06
mRNA TRIM9 CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA MAP1B CTRPv2 pan-cancer AAC 0.19 1e-06
Download CSV